Literature DB >> 21558392

Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling.

Tine S Mantoni1, Serena Lunardi, Osama Al-Assar, Atsushi Masamune, Thomas B Brunner.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by a strong desmoplastic reaction where the stromal compartment often accounts for more than half of the tumor volume. Pancreatic stellate cells (PSC) are a central mediator of desmoplasia. There is increasing evidence that desmoplasia is contributing to the poor therapeutic response of PDAC. We show that PSCs promote radioprotection and stimulate proliferation in pancreatic cancer cells (PCC) in direct coculture. Our in vivo studies show PSC-dependent radioprotection in response to a single dose and to fractionated radiation. Abrogating β1-integrin signaling abolishes the PSC-mediated radioprotection in PCCs. Furthermore, this effect is independent of PI3K (phosphoinositide 3-kinase) but dependent on FAK. Taken together, we show for the first time that PSCs promote radioprotection of PCCs in a β1-integrin-dependent manner. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558392      PMCID: PMC3097171          DOI: 10.1158/0008-5472.CAN-10-1633

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.

Authors:  Thomas Armstrong; Graham Packham; Lindsay B Murphy; Adrian C Bateman; John A Conti; David R Fine; Colin D Johnson; R Christopher Benyon; John P Iredale
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

2.  Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line.

Authors:  D Banasiak; A R Barnetson; R A Odell; H Mameghan; P J Russell
Journal:  Radiat Oncol Investig       Date:  1999

Review 3.  Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

Authors:  J M Brown; B G Wouters
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

4.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells.

Authors:  Alain Vonlaufen; Swapna Joshi; Changfa Qu; Phoebe A Phillips; Zhihong Xu; Nicole R Parker; Cheryl S Toi; Romano C Pirola; Jeremy S Wilson; David Goldstein; Minoti V Apte
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 5.  Pancreatic stellate cells--role in pancreas cancer.

Authors:  Max G Bachem; Shaoxia Zhou; Karin Buck; Wilhelm Schneiderhan; Marco Siech
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

Review 6.  Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis.

Authors:  Atsushi Masamune; Takashi Watanabe; Kazuhiro Kikuta; Tooru Shimosegawa
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

7.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Authors:  Catherine C Park; Hui J Zhang; Evelyn S Yao; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression.

Authors:  Rosa F Hwang; Todd Moore; Thiruvengadam Arumugam; Vijaya Ramachandran; Keith D Amos; Armando Rivera; Baoan Ji; Douglas B Evans; Craig D Logsdon
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

9.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

Authors:  Kenneth P Olive; Michael A Jacobetz; Christian J Davidson; Aarthi Gopinathan; Dominick McIntyre; Davina Honess; Basetti Madhu; Mae A Goldgraben; Meredith E Caldwell; David Allard; Kristopher K Frese; Gina Denicola; Christine Feig; Chelsea Combs; Stephen P Winter; Heather Ireland-Zecchini; Stefanie Reichelt; William J Howat; Alex Chang; Mousumi Dhara; Lifu Wang; Felix Rückert; Robert Grützmann; Christian Pilarsky; Kamel Izeradjene; Sunil R Hingorani; Pearl Huang; Susan E Davies; William Plunkett; Merrill Egorin; Ralph H Hruban; Nigel Whitebread; Karen McGovern; Julian Adams; Christine Iacobuzio-Donahue; John Griffiths; David A Tuveson
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

10.  ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase.

Authors:  P S Hodkinson; T Elliott; W S Wong; R C Rintoul; A C Mackinnon; C Haslett; T Sethi
Journal:  Cell Death Differ       Date:  2006-01-27       Impact factor: 15.828

View more
  85 in total

1.  Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Anusha Kalbasi; Chad Komar; Graham M Tooker; Mingen Liu; Jae W Lee; Whitney L Gladney; Edgar Ben-Josef; Gregory L Beatty
Journal:  Clin Cancer Res       Date:  2016-06-28       Impact factor: 12.531

Review 2.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

3.  Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

Authors:  Albert Lo; Liang-Chuan S Wang; Steven M Albelda; Ellen Puré; John Scholler; James Monslow; Diana Avery; Kheng Newick; Shaun O'Brien; Rebecca A Evans; David J Bajor; Cynthia Clendenin; Amy C Durham; Elizabeth L Buza; Robert H Vonderheide; Carl H June
Journal:  Cancer Res       Date:  2015-05-15       Impact factor: 12.701

Review 4.  Cancer stem cell plasticity and tumor hierarchy.

Authors:  Marina Carla Cabrera; Robert E Hollingsworth; Elaine M Hurt
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

5.  Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance.

Authors:  Simona Dalin; Mark R Sullivan; Allison N Lau; Beatrice Grauman-Boss; Helen S Mueller; Emanuel Kreidl; Silvia Fenoglio; Alba Luengo; Jacqueline A Lees; Matthew G Vander Heiden; Douglas A Lauffenburger; Michael T Hemann
Journal:  Cancer Res       Date:  2019-09-04       Impact factor: 12.701

6.  Cross-species analysis of nicotine-induced proteomic alterations in pancreatic cells.

Authors:  Darwin L Conwell; Hanno Steen; Joao A Paulo; Raul Urrutia; Vivek Kadiyala; Peter Banks
Journal:  Proteomics       Date:  2013-05       Impact factor: 3.984

7.  Generation of an in vitro 3D PDAC stroma rich spheroid model.

Authors:  Matthew J Ware; Vazrik Keshishian; Justin J Law; Jason C Ho; Carlos A Favela; Paul Rees; Billie Smith; Sayeeduddin Mohammad; Rosa F Hwang; Kimal Rajapakshe; Cristian Coarfa; Shixia Huang; Dean P Edwards; Stuart J Corr; Biana Godin; Steven A Curley
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

8.  Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.

Authors:  Miao Wang; Mary Topalovski; Jason E Toombs; Christopher M Wright; Zachary R Moore; David A Boothman; Hiromi Yanagisawa; Huamin Wang; Agnieszka Witkiewicz; Diego H Castrillon; Rolf A Brekken
Journal:  Cancer Res       Date:  2015-11-17       Impact factor: 12.701

9.  Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.

Authors:  Paul A Toste; Andrew H Nguyen; Brian E Kadera; Mindy Duong; Nanping Wu; Irmina Gawlas; Linh M Tran; Mihir Bikhchandani; Luyi Li; Sanjeet G Patel; David W Dawson; Timothy R Donahue
Journal:  Mol Cancer Res       Date:  2016-03-15       Impact factor: 5.852

Review 10.  Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.